Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD of Meihua International Medical Technologies Co., Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Meihua International Medical Technologies Co., Ltd. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and change rate from Q4 2018 to Q2 2025.
  • Meihua International Medical Technologies Co., Ltd. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Jun 2025 was $16,902,462, a 8.6% decline year-over-year.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

Meihua International Medical Technologies Co., Ltd. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $16,902,462 -$1,588,173 -8.6% 30 Jun 2025 6-K 18 Sep 2025 2025 Q2
Q4 2024 $17,288,952 +$362,074 +2.1% 31 Dec 2024 6-K 18 Sep 2025 2025 Q2
Q2 2024 $18,490,635 +$629,421 +3.5% 30 Jun 2024 6-K 18 Sep 2025 2025 Q2
Q4 2023 $16,926,878 -$9,809,822 -37% 31 Dec 2023 6-K 18 Sep 2025 2025 Q2
Q2 2023 $17,861,214 -$16,804,314 -48% 30 Jun 2023 6-K 20 Sep 2024 2024 Q2
Q4 2022 $26,736,700 +$18,587,424 +228% 31 Dec 2022 20-F 25 Apr 2025 2024 FY
Q2 2022 $34,665,528 30 Jun 2022 6-K 02 Oct 2023 2023 Q2
Q4 2021 $8,149,276 +$961,942 +13% 31 Dec 2021 20-F 25 Apr 2025 2024 FY
Q4 2020 $7,187,334 -$8,843,521 -55% 31 Dec 2020 20-F 24 Apr 2024 2023 FY
Q4 2019 $16,030,855 +$1,227,232 +8.3% 31 Dec 2019 20-F/A 29 Aug 2023 2022 FY
Q4 2018 $14,803,623 31 Dec 2018 20-F 29 Jul 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.